• 1. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 2. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 3. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 4. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 5. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110

Comprehensive Overview of 2-METHYL-2-(TRIFLUOROMETHYL)BUTANOIC ACID (CAS No. 1365969-07-8)

2-METHYL-2-(TRIFLUOROMETHYL)BUTANOIC ACID (CAS No. 1365969-07-8) is a specialized organic compound gaining attention in pharmaceutical and agrochemical research due to its unique structural properties. The presence of a trifluoromethyl group enhances its metabolic stability and lipophilicity, making it valuable for drug design. Researchers are increasingly exploring its applications in small-molecule therapeutics and catalyst systems, aligning with trends in green chemistry and sustainable synthesis.

The compound’s sterically hindered carboxylic acid moiety allows selective reactivity, a feature leveraged in peptide coupling and bioconjugation techniques. Recent studies highlight its role in proteolysis-targeting chimeras (PROTACs), a hot topic in targeted protein degradation therapies. Its CAS No. 1365969-07-8 is frequently searched alongside terms like "fluorinated building blocks" and "high-value intermediates," reflecting industry demand for tailor-made synthons.

From a synthetic perspective, 2-METHYL-2-(TRIFLUOROMETHYL)BUTANOIC ACID is synthesized via Grignard reactions or electrophilic trifluoromethylation, methods optimized for scalable production. Its low toxicity profile (non-GHS classified) makes it suitable for API development, addressing the growing need for safer fluorochemicals. Analytical data (NMR, HPLC) confirm >98% purity, meeting GMP standards for preclinical use.

Environmental considerations are pivotal. The compound’s persistence and bioaccumulation potential are under scrutiny, mirroring broader concerns about PFAS alternatives. Regulatory bodies emphasize readily biodegradable designs, positioning 1365969-07-8 as a candidate for eco-friendly fluorophores in imaging agents.

Market-wise, suppliers list it under custom fluorination services, catering to CRISPR-based research and mRNA vaccine adjuvants. Patent filings reveal utility in OLED materials and liquid crystals, tapping into the electronics boom. SEO-optimized queries like "CAS 1365969-07-8 supplier" or "trifluoromethylated carboxylic acid uses" reflect commercial interest.

In conclusion, 2-METHYL-2-(TRIFLUOROMETHYL)BUTANOIC ACID exemplifies innovation at the nexus of medicinal chemistry and material science. Its versatility answers pressing needs in precision medicine and clean energy technologies, ensuring sustained relevance in R&D pipelines worldwide.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)